Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

The new lung cancer screening program needs to be independently evaluated to keep it on track, and to minimise the harms.

The majority of patients with the most common advanced or metastatic cancers in the United States do not undergo ...

During a live event, Neal E. Ready, MD, and participants discussed what factors justify using PD-1 plus CTLA-4 inhibitor and ...

Session ID: 2025-07-01:c3d96494478f7322ba15e67b Player Element ID: Vd5cd1b33_dfb7_4cb6_a47a_a289603d2ac9_6374240200112 ...

While metastatic lung cancer can rarely be cured, improvements in the detection and treatment of brain metastases are allowing people to live longer, with a higher quality of life.

Whatever the cause, it's important to find lung cancer early when it's curable. That's why the Lung Force walk comes together every year to raise awareness. "It is very important.

DULUTH — Since being diagnosed with Stage 4 lung cancer in November 2024, running has taken on a new meaning for 37-year-old Caitlin Quinn. A mother of three children between 2 and 7, running ...

GEMSTONE-302 was a phase 3 trial in patients with treatment-naive metastatic squamous or non-squamous non-small-cell lung cancer (NSCLC), showed significant improvement in progression-free survival ...

Lung cancer is one of the most frequently diagnosed cancers and the leading cause of cancer-related deaths worldwide with an estimated 2 million new cases and 1·76 million deaths per year. Substantial ...

positive topline efficacy results from its completed U.S. Phase 1B/2 clinical trial evaluating Annamycin for the treatment of Soft Tissue Sarcoma Lung Metastases (“STS lung mets”) (MB-107).